BetterLife Files Amended and Restated Offering Document for Offering of Units Pharmaceutical Investing
KEYTRUDA® Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line Treatment for Advanced Malignant Pleural Mesothelioma Life Science Investing
Omineca Announces Upsized and Fully Allocated $2.8 Million Brokered Financing of Flow-Through Units Pharmaceutical Investing
Betterlife Publishes Promising Results from a Study Titled "A Non-Hallucinogenic LSD Analog With Therapeutic Potential For Mood Disorders" Pharmaceutical Investing
Bristol Myers Squibb to Report Results for First Quarter 2023 on April 27, 2023 Pharmaceutical Investing
Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc. Pharmaceutical Investing
BOTOX® Cosmetic Partners with IFundWomen to Help Close the Confidence Gap for Women Entrepreneurs Pharmaceutical Investing
